Women: latest news

Women resources

  • Bacterial vaginosis

    Women may get bacterial vaginosis when the balance of normal bacteria in their vagina becomes disrupted.It is common and various activities seem to increase the...

    From: Factsheets

    Information level Level 2
  • Contraception

    Your choice of contraception will depend on your situation and preferences.There are possible interactions between some hormonal contraceptives and some anti-HIV drugs. Your HIV treatment needs to be...

    From: Factsheets

    Information level Level 2
  • Bone problems and HIV

    When your bones are thinner, a trip or fall can result in a broken bone. Exercise and other lifestyle changes are good for your bones. People aged 50+ and...

    From: Factsheets

    Information level Level 2
  • Menopause and HIV

    The menopause is a natural part of each woman’s ageing process. Knowing what symptoms to expect during the menopause can help you deal with the experience. Hormone replacement therapy...

    From: Factsheets

    Information level Level 2
  • Health monitoring during pregnancy

    If a woman has HIV, it is possible for it to be passed on to her baby during pregnancy or delivery, or through breastfeeding. For this reason,...

    From: Booklets

    Information level Level 2
  • HIV and having a baby

    Women living with HIV can give birth without passing on HIV to the baby.Your options for conception will depend on your health and your partner’s...

    From: Factsheets

    Information level Level 2
  • Having a baby

    Lots of people with HIV have had babies without passing on the infection. To do so, you need some help from your doctor.If you are...

    From: The basics

    Information level Level 1
  • HIV & women

    The booklet is for women living with HIV. It includes information on wellbeing, HIV treatment, sexual health, contraception and pregnancy....

    From: Booklets

    Information level Level 2
  • HIV treatment, pregnancy and contraception

    When HIV treatment is used during pregnancy, it protects your health as well as playing an important role in preventing HIV being passed on from you to...

    From: Booklets

    Information level Level 2
  • HIV & Pregnancy

    Personalised information about having a baby. (Smartphone version available.)...

    From: Resources

  • HIV & Contraception

    ...

    From: Resources

  • Pregnancy

    Since 1999 it has been routine for pregnant women in the UK to be offered an HIV test. The test was introduced in recognition of...

    From: HIV transmission & testing

    Information level Level 4
  • Cervical cancer

    Cervical cancer is caused by certain strains of human papillomavirus (HPV).Cervical screening tests for changes in cells that can lead to cervical cancer.Treatment for cell...

    From: Factsheets

    Information level Level 2
  • Women's health issues

    Globally, HIV/AIDS is the leading cause of morbidity and mortality among women aged 15 to 49 years. A majority of women acquire HIV as a result of unprotected...

    From: HIV treatments directory

    Information level Level 4
  • Mother-to-child transmission

    HIV can pass from an HIV-positive mother to her child:During pregnancy – the foetus is infected by HIV crossing the placenta.During childbirth – the...

    From: HIV transmission & testing

    Information level Level 4

Women features

Women in your own words

Women news from aidsmap

More news

Women news selected from other sources

  • I'm A Grandmother, I Have HIV, And I Can't Pass It On

    This is one of the biggest developments since the start of the HIV epidemic, yet people don’t know it. It means people can have sex, relationships and children, with someone living with HIV, without becoming infected. For some it can sound a bit unreal - but it’s true. And if everyone know this we could stop HIV stigma.

    19 July 2017 | HuffPost UK
  • Men often control use of women’s HIV prophylactic gel in Zambia

    In Zambia, men often control the use of a microbicide gel that is meant to give women autonomy in preventing HIV infection, according to researchers. Use of the vaginal gel, which is now in phase 3 trials, is limited by social norms that entrench male dominance, they wrote in Global Public Health.

    17 July 2017 | Healio
  • Support Groups a Driver to PrEP Rollout in Kenya

    Kenya passed a major milestone in the fight against HIV on May 4, 2017 when it launched a nation-wide initiative to bring oral PrEP (pre-exposure prophylaxis), antiretroviral drugs for preventing HIV, to the people who need it. A team made up of LVCT Health staff and AVAC staff recently visited the implementing sites to gather stories and collect lessons learnt as part of the OPTIONS project. We interviewed providers, adherence counselors and people using PrEP who shared their journeys of PrEP uptake and adherence.

    28 June 2017 | AVAC
  • Women’s bacteria thwarted attempt at anti-HIV vaginal gel

    Creating new HIV prevention tools for women has proven frustratingly slow and researchers have found another hurdle: bacteria in the reproductive tract.

    02 June 2017 | STAT
  • HIV status may affect the progression of HPV infection to cervical pre-cancer

    HIV-positive women were more likely to have human papillomavirus infection progress to pre-cancerous cervical lesions

    02 June 2017 | Science Daily
  • Unprecedented extension of Global Gag Rule puts HIV programmes at risk

    The Alliance comments: "In implementing this controversial policy, the US government will force organisations to choose between either women’s right to comprehensive health services and advice, or vital support for tens of millions of people living with HIV. This is an impossible dilemma for organisations like ours. We urge the US government to re-evaluate its stance, to ensure that we stay on target to end AIDS by 2030." See also https://www.theguardian.com/global-development/2017/feb/14/bill-and-melinda-gates-trumps-global-gag-rule-endangers-millions-women-girls-us-funding

    17 May 2017 | International HIV/AIDS Alliance
  • HIV, Vaginal Sex and PrEP Initiation: What Should You Tell Your Patients or Clients?

    This year, pre-exposure prophylaxis (PrEP) advocates noted a stunning disconnect between key organizations that issue guidelines on the use of tenofovir/emtricitabine (TDF/FTC, Truvada) for HIV prevention: The United States Centers for Disease Control and Prevention (CDC) continues to say that people need 20 days of daily TDF/FTC before they can consider themselves protected from vaginal HIV exposure -- but the World Health Organization (WHO) has stated that just seven days of the drug is enough.

    03 May 2017 | The Body Pro
  • Nelly Mugo—rolling out PrEP in Kenya

    Nelly Mugo has had a central role in building evidence for PrEP, as a co-author on the Partners PrEP study. Most of her current work is focused on scale-up and roll-out of PrEP.

    28 April 2017 | The Lancet (free registration required)
  • The living legacy of the Global Plan: eliminating HIV in children

    The Journal of Acquired Immune Deficiency Syndromes (JAIDS) has released a special supplement on the incredible journey of the Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive (Global Plan), which documents the history of the Global Plan and outlines what the future holds as efforts to end AIDS among women, children and adolescents accelerate.

    20 April 2017 | UNAIDS
  • Minority Within A Minority: Women Ageing With HIV

    My research is a three year project, exploring what it is like to be an older women with HIV, how the social and physical experiences of ageing are affected by HIV, and what support exists or is needed to enable older women living with HIV to age well.

    09 March 2017 | Huffington Post
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.